Keywords: bb-10010, preliminary, phase, results, safety, data, british

BB-10010 Preliminary Phase I Results

Article | 07 November 1994

Print This

Preliminary Phase I safety data with British Biotech's stem cell chemokine BB-10010 has shown the product to be well tolerated ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in